French shipping giant CMA CGM agreed to buy 47.6% of port terminal operator Santos Brasil for 6.3 billion reais ($1.2 billion ...

Real-world data showed reductions in healthcare resource utilization and improved glycemic control over 1 year with ...

Neither Gene Seroka nor George Goldman saw evidence that East Coast-bound vessels will be diverted after a possible Oct. 1 ...

Eversense 365 is a fully-implantable CGM with a 365-day sensor, making it the first 1-year CGM option for diabetes management ...

Senseonics (NYSE:SENS) announced today that it received FDA clearance for its next-generation Eversense 365 CGM system.

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of ...

After collecting FDA green lights for 90- and 180-day versions, the agency has cleared the latest generation of the Eversense ...

Bunkerspot provides news, in-depth analysis, expert comment and price indications for the global marine fuels industry ...

Veri, which makes a continuous glucose monitor, has announced that it has joined ŌURA, which makes the Oura Ring.

Dexcom Inc. revealed data from several studies showing significant benefits of its continuous glucose monitoring technology ...

SAO PAULO, Sept 22 (Reuters) - French shipping giant CMA CGM agreed to buy 47.6% of port terminal operator Santos Brasil for 6.3 billion reais ($1.2 billion), and will launch a takeover bid for the ...